October 2021 in “DOAJ (DOAJ: Directory of Open Access Journals)”
In this hospital-based cross-sectional study, researchers observed that trichoscopy effectively differentiates between severe and mild male pattern hair loss by identifying specific features such as yellow and white dots, vellus hair, and hair shaft diversity.
March 2026 in “Zenodo (CERN European Organization for Nuclear Research)”
This paper documents a case of natural reversal of moderate-to-severe androgenetic alopecia without medical intervention, but emphasizes it is an individual observation not generalizable to broader populations.
December 2025 in “Zenodo (CERN European Organization for Nuclear Research)”
In this documented case report, the researcher detailed a natural reversal of moderate-to-severe androgenetic alopecia without any medical interventions by systematically observing and analyzing hair regrowth over time, emphasizing that these findings are purely from personal practice and not applicable to broader populations.
This study found that for managing early-onset androgenetic alopecia in men, minoxidil monotherapy is cost-effective at a $50,000 willingness-to-pay threshold, while combining minoxidil with platelet-rich plasma becomes cost-effective at a $100,000 threshold.
The conversation discusses designing a study to examine the relationship between creatine and hair loss, suggesting groups with different creatine and finasteride usage. It emphasizes the need for consistent scalp examinations, DHT level measurements, and considers the impact of exercise on hormone levels.
Hair transplants for NW7 individuals are challenging due to limited donor hair, often resulting in thin coverage unless body or beard hair is used. Treatments like minoxidil and finasteride are mentioned to support hair density and growth.
PP405 is a new topical treatment for hair loss, showing promise in trials but still requires finasteride for maintenance. There is skepticism about its effectiveness and safety, with concerns about needing finasteride to maintain results.
The conversation discusses hair loss treatments, focusing on the use of topical minoxidil, microneedling, finasteride, and dutasteride, while debating the role of testosterone and DHT in hair loss. It also touches on the potential liver health impacts of these treatments and the genetic sensitivity of hair follicles to androgens.
A user added sandalore to minoxidil for hair loss, observing some vellus hair growth and less scalp inflammation. Others tried sandalore with mixed results, discussing dosage and effectiveness compared to minoxidil and finasteride.